title: Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype.
authors.forename: Kyle T S
authors.initials: KT
authors.lastname: Pattinson
authors.forename: Richard
authors.initials: R
authors.lastname: Rogers
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Mayhew
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: MacIntosh
authors.forename: Michael C
authors.initials: MC
authors.lastname: Lee
authors.forename: Richard G
authors.initials: RG
authors.lastname: Wise
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology*; D001057:Apolipoproteins E / Q000235:genetics*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005838:Genotype; D006801:Humans; D008032:Limbic System / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D010880:Piperidines / Q000494:pharmacology*; D000077208:Remifentanil; D015203:Reproducibility of Results; D012107:Research Design
chemical_list: D000701:Analgesics, Opioid; D001057:Apolipoproteins E; D010880:Piperidines; D000077208:Remifentanil